In the WHO classification of myeloid malignancies (2008 revision) (1), ABL has been integrated as a distinct entity and defined as an acute myeloid leukemia (AML) in which the primary differentiation is to basophils. This evidence concerns the gene ABL1 and myeloid neoplasm.